Sechat digs into the details In response to a case involving a discontinuation of treatment of a patient using cannabidiol, the Steering Committee of the Federal Senate sent to the Ministry of Health a requisition requesting clarifications on the suspension of cannabidiol Nabix®, acquired via judicial demand by the Unified Health System (SUS). The case refers to a […]